Vasili Berdoukas

719 total citations
14 papers, 520 citations indexed

About

Vasili Berdoukas is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vasili Berdoukas has authored 14 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Genetics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vasili Berdoukas's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (11 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Vasili Berdoukas is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (11 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Vasili Berdoukas collaborates with scholars based in United States, Australia and Italy. Vasili Berdoukas's co-authors include B Modell, Bernadette Modell, Antonella Meloni, John C. Wood, Alessia Pepe, Thomas D. Coates, Mammen Puliyel, David Ford, Marcus R. Vowels and Dudley J. Pennell and has published in prestigious journals such as New England Journal of Medicine, Medicine and The Medical Journal of Australia.

In The Last Decade

Vasili Berdoukas

14 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasili Berdoukas United States 11 384 369 81 61 42 14 520
A Mangiagli Italy 10 390 1.0× 359 1.0× 93 1.1× 45 0.7× 56 1.3× 20 494
S Terzoli Italy 8 652 1.7× 541 1.5× 136 1.7× 84 1.4× 65 1.5× 17 766
Gabor Domokos Switzerland 11 849 2.2× 854 2.3× 158 2.0× 106 1.7× 20 0.5× 33 951
Pustika Amalia Wahidiyat Indonesia 10 295 0.8× 245 0.7× 78 1.0× 24 0.4× 19 0.5× 40 398
Paolo Rigano Italy 17 450 1.2× 367 1.0× 121 1.5× 19 0.3× 44 1.0× 33 524
Áurea Cervera Spain 11 130 0.3× 152 0.4× 49 0.6× 42 0.7× 46 1.1× 40 379
Fatma Soliman Elsayed Ebeid Egypt 11 168 0.4× 140 0.4× 51 0.6× 21 0.3× 48 1.1× 58 347
A. Torres Spain 14 71 0.2× 267 0.7× 61 0.8× 50 0.8× 51 1.2× 22 473
Annalisa Agus Italy 6 793 2.1× 756 2.0× 196 2.4× 128 2.1× 13 0.3× 8 915
Muhammad Saboor Saudi Arabia 11 80 0.2× 148 0.4× 28 0.3× 35 0.6× 47 1.1× 51 355

Countries citing papers authored by Vasili Berdoukas

Since Specialization
Citations

This map shows the geographic impact of Vasili Berdoukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasili Berdoukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasili Berdoukas more than expected).

Fields of papers citing papers by Vasili Berdoukas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasili Berdoukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasili Berdoukas. The network helps show where Vasili Berdoukas may publish in the future.

Co-authorship network of co-authors of Vasili Berdoukas

This figure shows the co-authorship network connecting the top 25 collaborators of Vasili Berdoukas. A scholar is included among the top collaborators of Vasili Berdoukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasili Berdoukas. Vasili Berdoukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fragodimitri, Christina, et al.. (2023). Successful chelation in beta-thalassemia major in the 21st century. Medicine. 102(41). e35455–e35455. 2 indexed citations
2.
Wahidiyat, Pustika Amalia, et al.. (2019). Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major. Blood Cells Molecules and Diseases. 77. 67–71. 10 indexed citations
3.
Wahidiyat, Pustika Amalia, et al.. (2017). Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging. Hematology. 22(8). 1–7. 40 indexed citations
4.
Meloni, Antonella, Mammen Puliyel, Alessia Pepe, et al.. (2014). Cardiac iron overload in sickle‐cell disease. American Journal of Hematology. 89(7). 678–683. 64 indexed citations
5.
Berdoukas, Vasili, et al.. (2012). Treating thalassemia major-related iron overload: the role of deferiprone. Journal of Blood Medicine. 3. 119–119. 47 indexed citations
6.
Meloni, Antonella, Jon Detterich, Vasili Berdoukas, et al.. (2012). Comparison of biventricular dimensions and function between pediatric sickle‐cell disease and thalassemia major patients without cardiac iron. American Journal of Hematology. 88(3). 213–218. 19 indexed citations
7.
Smith, Gillian, Francisco Alpendurada, Mohammed H Alam, et al.. (2011). Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload. Journal of Cardiovascular Magnetic Resonance. 13(1). 34–34. 33 indexed citations
8.
Daar, Shahina, Saeed Ahmed, & Vasili Berdoukas. (2010). Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.. PubMed. 10(3). 401–4. 1 indexed citations
9.
Berdoukas, Vasili, et al.. (2005). Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy. The Hematology Journal. 5(7). 572–578. 18 indexed citations
10.
Berdoukas, Vasili, et al.. (2000). The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1). Transfusion Science. 23(3). 239–240. 16 indexed citations
11.
Vowels, Marcus R., Vasili Berdoukas, David Ford, et al.. (1993). Correction of X-Linked Lymphoproliferative Disease by Transplantation of Cord-Blood Stem Cells. New England Journal of Medicine. 329(22). 1623–1625. 58 indexed citations
12.
Freeman, Anthony P., et al.. (1989). Sustained normalization of cardiac function by chelation therapy in thalassaemia major. Clinical & Laboratory Haematology. 11(4). 299–307. 22 indexed citations
13.
Vowels, Marcus R., Vasili Berdoukas, P.R.L.C. Lam-Po-Tang, & David Ford. (1986). Bone‐marrow transplantation for thalassaemia. The Medical Journal of Australia. 144(7). 372–374. 6 indexed citations
14.
Berdoukas, Vasili, Bernadette Modell, & B Modell. (1984). The Clinical Approach to Thalassaemia. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Mangiagli Breakdown of academic impact, for papers by S Terzoli Breakdown of academic impact, for papers by Gabor Domokos Breakdown of academic impact, for papers by Pustika Amalia Wahidiyat Breakdown of academic impact, for papers by Paolo Rigano Breakdown of academic impact, for papers by Áurea Cervera Breakdown of academic impact, for papers by Fatma Soliman Elsayed Ebeid Breakdown of academic impact, for papers by A. Torres Breakdown of academic impact, for papers by Annalisa Agus Breakdown of academic impact, for papers by Muhammad Saboor
Rankless by CCL
2026